SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros is trending following the FDA approval of YARTEMLEA, making it the first and only approved therapy for the life-threatening transplant-associated thrombotic microangiopathy (TA-TMA). The community is celebrating this significant milestone, with discussions centered on the stock's perceived undervaluation, potential for a short squeeze, and heightened speculation around a buyout, especially given a prior licensing deal with Novo Nordisk.

Biohaven Ltd. is a global clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of therapies for people with neurological and neuropsychiatric diseases. The company was founded on May 2, 2022 and is headquartered in New Haven, CT.

Biohaven Ltd

Biohaven Pharmaceutical Holding Company Ltd

Biohaven is trending following a recent clinical trial failure for its depression drug, a development released during a holiday period that drew community criticism for its timing. However, investor attention is quickly shifting to the company's robust pipeline, particularly upcoming data for its epilepsy, obesity, and oncology programs. Significant insider buying after a recent offering has also fueled renewed confidence, signaling a belief in future growth despite prior regulatory setbacks.

NANO Nuclear Energy, Inc. is a microreactor and nuclear technology company, which provides supply energy services. Its products in technical development are ZEUS, a solid core battery reactor, and ODIN, a low-pressure coolant reactor. The company is founded by Jiang Yu in February, 2022 and is headquartered in New York, NY.

Nano Nuclear Energy Inc.

Nano Nuclear Energy is trending following the successful closing of an oversubscribed $400 million private placement and major operational milestones, including beginning drilling for its KRONOS microreactor prototype and securing significant R&D incentives. Community discussion highlights the strong institutional backing and positive progress, fueling optimism within the broader nuclear energy sector as demand for advanced microreactors surges, particularly to power AI data centers.

Dynavax Technologies Corp. is a biopharmaceutical company, which engages in the provision of discovery, development, and commercialization of novel vaccines and immuno-oncology therapeutics. Its product includes HEPLISAV-B, which prevents infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older. The company was founded by Lawrence M. Lichtenstein, Dennis A. Carson, and Eyal Raz on August 29, 1996 and is headquartered in Emeryville, CA.

Dynavax Technologies Corp.

Dynavax (DVAX) is trending due to the announcement that Sanofi will acquire the company for cash, a strategic move to bolster its adult immunization portfolio with DVAX's Hepatitis B vaccine, Heplisav-B, and a shingles candidate. The community is actively debating the acquisition price, with many long-term holders expressing disappointment and questioning if the company was undersold, while some speculate about potential counter-offers. This acquisition reflects ongoing consolidation in the biotech vaccine sector, integrating DVAX's assets into a larger pharmaceutical framework.

Shiba Inu (SHIB) is a meme token which began as a fun currency and has now transformed into a decentralized ecosystem. During the initial launch, 50% of the supply was allocated into Vitalik Buterin's ethereum wallet.   As a result of that, Vitalik proceeded to donate 10% of his SHIB holdings to a COVID-19 relief effort in India and the remaining 40% is burnt forever. That donation was worth about $1 billion at that time, which makes it one of the largest donation ever in the world.  What is the Shiba Inu community working on right now? The Shiba Inu team launched a decentralized exchange called Shibaswap with 2 new tokens, LEASH and BONE. LEASH is a scarce supply token that is used to offer incentives on Shibaswap. BONE is the governance token for holders to vote on proposals on Doggy DAO.

Shiba Inu

Shiba Inu is actively trending as its community intensely discusses a potential price reversal, with many holding onto hopes for substantial gains following recent market dips. While some vocal participants express frustration and question its long-term viability, others remain confident in its community-driven momentum and look for signs of a breakout, often contrasting its appeal with more infrastructure-focused crypto projects.

Agios Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in a research engine, multiple novels, and investigational therapies in preclinical development. It focuses on cellular metabolism and classical hematology. The company was founded by Lewis Clayton Cantley, Tak W. Mak, Craig B. Thompson and Shin-Shan Michael Su on August 7, 2007 and is headquartered in Cambridge, MA.

Agios Pharmaceuticals Inc

Agios Pharmaceuticals is trending following its FDA approval of AQVESME for alpha- or beta-thalassemia, positioning it as the sole approved treatment for these indications. The community is largely optimistic about this significant milestone, anticipating upward momentum despite some initial caution regarding its future availability and the mandated REMS program. This approval marks a key development in the rare blood disorder sector for the company.

Babcock & Wilcox Enterprises, Inc. engages in the provision of fossil and renewable power generation and environmental equipment. It operates through the following segments: B&W Renewable, B&W Environmental, and B&W Thermal. The B&W Renewable segment supports a circular economy, diverting waste from landfills to use for power generation and replacing fossil fuels, while recovering metals and reducing emissions. The B&W Environmental segment focuses on systems for cooling, ash handling, particulate control, nitrogen oxides and sulfur dioxides removal, chemical looping for carbon control, and mercury control. The B&W Thermal segment offers steam generation equipment, aftermarket parts, construction, maintenance, and field services for plants in the power generation, oil and gas, and industrial sectors. The company was founded by George H. Babcock, Stephen Wilcox, Jr., and Joseph P. Manton in 1856 and is headquartered in Akron, OH.

Babcock & Wilcox Enterprises Inc

Babcock & Wilcox is trending due to recent significant contract announcements, highlighted by a $1.5 billion notice to proceed with Applied Digital for AI data center power, alongside new carbon capture and refinery projects. The community views BW as a critical player in the burgeoning AI energy infrastructure, with ongoing discussions around its long-term growth potential. While many are optimistic about the strategic pivot and debt reduction, some express caution regarding contract finalization timelines, potential share dilution, and the broader sector's valuation.

Aduro Clean Technologies, Inc. engages in the manufacture of oils and specialty chemicals using waste plastics. It focuses on hydrochemolytic technology to transform post-consumer polymer waste into a resource for the circular economy. It also develops a novel chemical conversion process to transform waste plastics and low grade renewable oils into renewable fuels and specialty chemicals. The company was founded on January 10, 2018 by Ofer Vicus and William Marcus Trygstad and is headquartered in Sarnia, Canada.

Aduro Clean Technologies Inc

Aduro Clean Technologies is seeing heightened conversation following a recent US$20 million public offering aimed at funding its demonstration-scale plant. Enthusiastic investors highlight the company's graduation from Shell's GameChanger program and new partnerships as strong validation for its unique recycling technology, while skeptics warn of a "pump and dump" lacking revenue and view the valuation as unsustainable.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is trending as the community discusses its potential for a buyout and strong revenue growth, particularly with Briumvi. Some analysts suggest the company is undervalued compared to industry peers, while others point to upcoming catalysts, like sub-Q data, that could drive the stock higher. Concerns remain about competition and market sentiment, with some looking for more aggressive promotion of Briumvi.

Exodus Movement, Inc. develops blockchain asset investors platform to secure, exchange and manage wealth inside one application. The company was founded by Daniel Castagnoli and Jon Paul Richardson in 2015 and is headquartered in Omaha, NE.

Exodus Movement Inc - Ordinary Shares - Class A

Exodus Movement is trending as a key player in the evolving digital asset landscape, celebrated for its self-custodial crypto wallet and pioneering tokenized stock on the Algorand blockchain. Community sentiment emphasizes its strong financial position, zero debt, and strategic expansion into Web3 and stablecoin payments, drawing comparisons to competitors for its decentralized approach. Analysts are upgrading ratings, fueling discussions around its significant undervaluation and growth potential amid a re-energized crypto market.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Miromatrix Medical, Inc. operates as a biotechnology company, which engages in the development of biological human organs to solve the chronic shortage of transplantable organs. It offers perfusion decellularization and recellularization technology, as well as organ-derived biological products such as MIROMESH and MIRODERM for soft tissue reinforcement and advanced wound care. The company was founded in 2009 by Doris A. Taylor and Cohen Robert and is headquartered in Eden Prairie, MN.

MIRO
Miromatrix Medical Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest MIRO News

MIROMiromatrix Medical Inc